secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001193125-24-248691
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health closes $5.2B multi-tranche notes offering; proceeds for general corporate purposes
--------------------------------------------------------------------------------

- Issued $5.2B aggregate principal across six series: 2026 (4.500%), 2030 (4.750%), 2031 (4.950%), 2035 (5.200%), 2055 (5.700%), 2064 (5.850%).
- Net proceeds of approximately $5.138B after underwriting discounts and expenses.
- Proceeds intended for working capital, acquisitions, debt repayment, and share repurchases.
- Notes issued under existing indenture; underwriters include Citigroup, Morgan Stanley, Wells Fargo.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312524248691/0001193125-24-248691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312524248691/d888716d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-248691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer